Skip to main content
. 2018 Dec 10;19(2):1150–1158. doi: 10.3892/mmr.2018.9733

Table I.

Clinicopathological characteristics of the patients used in the present study.

Clinicopathological characteristic Patients with preeclampsia (n=29) Normal pregnant women (n=27) Healthy non-pregnant women (n=10) ANOVA F value; P-value
Maternal age at delivery (years) 31±7a,b 26±6 27±7 4.251; 0.015
BMI at blood draw (kg/m2) 28.7±6.3a,b 26.0±5.9b 21.6±1.6 4.912; 0.001
Gestational age at delivery (weeks) 37±2.1a 39±2.2 n.a. 2.376; <0.001
Primiparous women (%) 17 (58.6%) 16 (59.25%) n.a. 0.002; 0.961
Systolic blood pressure (mmHg) 155±49a,b 119±30 115±36 6.814; 0.001
Diastolic blood pressure (mmHg) 100±36a,b 77±26 74±33 4.593; 0.010
Fetal birth weight (g) 2,932±378c 3,212±212 n.a. 2.563; 0.013
Fetal growth restriction (%) 12 (41.4%)a 0 n.a. <0.001
a

P<0.001 vs. normal pregnant women

b

P<0.001 vs. healthy non-pregnant women

c

P<0.05 vs. normal pregnant women. Data are presented as the mean ± standard deviation for continuous variables and as number (percentage) for categorical variables. ANOVA, analysis of variance; BMI, body mass index; n.a., not applicable.